{
  "ticker": "IKT",
  "success": true,
  "price": {
    "current": 1.57,
    "currency": "USD",
    "day_high": 1.6,
    "day_low": 1.55,
    "52_week_high": 3.32,
    "52_week_low": 1.33
  },
  "market_cap": {
    "value": 190389264.0,
    "currency": "USD"
  },
  "shares_outstanding": 121267045.0,
  "volume": {
    "last": 318642,
    "average_30d": 504161
  },
  "valuation": {
    "pe_ratio": 3.3404257,
    "forward_pe": -6.28,
    "price_to_book": 1.9454771
  },
  "company_info": {
    "name": "Inhibikase Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 79594541.0,
    "total_liabilities": 6696243.0,
    "stockholders_equity": 72898298.0,
    "cash": 38269706.0,
    "marketable_securities": 39052511.0,
    "total_liquidity": 77322217.0,
    "total_debt": 0.0,
    "long_term_debt": null,
    "current_debt": null,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -10592730.0,
    "free_cash_flow": -10592730.0,
    "investing_cash_flow": -28746103.0,
    "financing_cash_flow": -134130.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 13261200.0,
    "research_and_development": 7649697.0,
    "interest_expense": null,
    "net_income": -11930280.0,
    "revenue": 0.0,
    "gross_profit": null,
    "ebitda": -13237513.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:48:03.660244",
    "url": "https://finance.yahoo.com/quote/IKT",
    "data_hash": "4d10a6be05938d04"
  }
}